DK1151010T3 - Humane polyklonale antistoffer fra antigene ikke-humane dyr - Google Patents
Humane polyklonale antistoffer fra antigene ikke-humane dyrInfo
- Publication number
- DK1151010T3 DK1151010T3 DK00907506T DK00907506T DK1151010T3 DK 1151010 T3 DK1151010 T3 DK 1151010T3 DK 00907506 T DK00907506 T DK 00907506T DK 00907506 T DK00907506 T DK 00907506T DK 1151010 T3 DK1151010 T3 DK 1151010T3
- Authority
- DK
- Denmark
- Prior art keywords
- human
- polyclonal antibodies
- antisera
- light chain
- domestic animal
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8777—Rabbit embryos
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/107—Rabbit
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Environmental Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Husbandry (AREA)
- Virology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11881099P | 1999-02-05 | 1999-02-05 | |
US13139899P | 1999-04-28 | 1999-04-28 | |
US13467499P | 1999-05-18 | 1999-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1151010T3 true DK1151010T3 (da) | 2006-01-09 |
Family
ID=27382221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00907506T DK1151010T3 (da) | 1999-02-05 | 2000-02-04 | Humane polyklonale antistoffer fra antigene ikke-humane dyr |
Country Status (10)
Country | Link |
---|---|
US (3) | US20020178456A1 (da) |
EP (1) | EP1151010B1 (da) |
JP (2) | JP5694623B2 (da) |
AT (1) | ATE307830T1 (da) |
AU (1) | AU2907200A (da) |
CA (1) | CA2362098C (da) |
DE (1) | DE60023451T2 (da) |
DK (1) | DK1151010T3 (da) |
ES (1) | ES2250105T3 (da) |
WO (1) | WO2000046251A2 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60023451T2 (de) * | 1999-02-05 | 2006-07-20 | Therapeutic Human Polyclonals, Inc., Mountain View | Aus nicht-menschlichen transgenen tieren gewonnene menschliche polyklonale antikörper |
AU7491800A (en) * | 1999-09-15 | 2001-04-17 | Therapeutic Human Polyclonals, Inc. | Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds |
US7129084B2 (en) * | 2000-08-03 | 2006-10-31 | Therapeutic Human Polyclonals, Inc. | Production of humanized antibodies in transgenic animals |
US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
US6586251B2 (en) * | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
US20050144655A1 (en) | 2000-10-31 | 2005-06-30 | Economides Aris N. | Methods of modifying eukaryotic cells |
JP2002316944A (ja) * | 2001-04-17 | 2002-10-31 | Chemo Sero Therapeut Res Inst | ヒトポリクローナル抗体組成物 |
RU2384059C2 (ru) | 2002-11-08 | 2010-03-20 | Киова Хакко Кирин Ко., Лтд. | Трансгенные копытные животные, имеющие пониженную активность прионного белка, и их применения |
AU2004257292A1 (en) | 2003-07-15 | 2005-01-27 | Therapeutic Human Polyclonals, Inc. | Humanized immunoglobulin loci |
JP2007533328A (ja) | 2004-04-22 | 2007-11-22 | キリンホールディングス株式会社 | トランスジェニック動物及びその用途 |
EP2064325B1 (en) | 2006-09-01 | 2011-12-07 | Therapeutic Human Polyclonals, Inc. | Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
EP3367786A1 (en) * | 2015-10-29 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Transgenic rabbit with common light chain |
WO2019129677A1 (en) | 2017-12-29 | 2019-07-04 | F. Hoffmann-La Roche Ag | Anti-vegf antibodies and methods of use |
EP3768079A4 (en) * | 2018-03-21 | 2021-12-08 | Crystal Bioscience Inc. | TRANSGENIC CHICKEN WHICH PRODUCES HUMAN ANTIBODIES |
CN117099741A (zh) | 2019-02-18 | 2023-11-24 | 百奥赛图(北京)医药科技股份有限公司 | 具有人源化免疫球蛋白基因座的经遗传修饰的非人动物 |
WO2020260326A1 (en) | 2019-06-27 | 2020-12-30 | F. Hoffmann-La Roche Ag | Novel icos antibodies and tumor-targeted antigen binding molecules comprising them |
AR119382A1 (es) | 2019-07-12 | 2021-12-15 | Hoffmann La Roche | Anticuerpos de pre-direccionamiento y métodos de uso |
AR119393A1 (es) | 2019-07-15 | 2021-12-15 | Hoffmann La Roche | Anticuerpos que se unen a nkg2d |
CA3182925A1 (en) | 2020-06-02 | 2021-12-09 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Genetically modified non-human animals with common light chain immunoglobulin locus |
AU2022423749A1 (en) | 2021-12-20 | 2024-06-13 | F. Hoffmann-La Roche Ag | Agonistic ltbr antibodies and bispecific antibodies comprising them |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567607A (en) * | 1981-10-28 | 1996-10-22 | Incell | Method of producing transgenic animals |
GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
AU633958B2 (en) * | 1989-07-25 | 1993-02-11 | Cell Genesys, Inc. | Homologous recombination for universal donor cells and chimeric mammalian hosts |
EP0463151B1 (en) * | 1990-01-12 | 1996-06-12 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
US5814318A (en) * | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
DE69127627T2 (de) * | 1990-08-29 | 1998-02-19 | Genpharm Int | Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper |
EP1288229A3 (en) * | 1991-12-17 | 2003-07-30 | GenPharm International, Inc. | Transgenic non human animals capable of producing heterologous antibodies |
AU3328493A (en) * | 1991-12-17 | 1993-07-19 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5453357A (en) * | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
AU5685894A (en) * | 1992-12-08 | 1994-07-04 | Linaeum Corporation | Audio transducer with flexible foam enclosure |
JPH08140528A (ja) * | 1993-12-03 | 1996-06-04 | Genpharm Internatl Inc | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
EP1978033A3 (en) * | 1995-04-27 | 2008-12-24 | Amgen Fremont Inc. | Human antibodies derived from immunized xenomice |
JPH11505107A (ja) * | 1995-04-28 | 1999-05-18 | アブジェニックス インク. | 免疫したゼノマウス(XenoMouse)に由来するヒト抗体 |
GB9823930D0 (en) * | 1998-11-03 | 1998-12-30 | Babraham Inst | Murine expression of human ig\ locus |
KR100345463B1 (ko) * | 1998-11-19 | 2003-01-08 | 주)녹십자 | B형간염바이러스의표면항원프리-s1에대한인간화항체및이의제조방법 |
DE60023451T2 (de) * | 1999-02-05 | 2006-07-20 | Therapeutic Human Polyclonals, Inc., Mountain View | Aus nicht-menschlichen transgenen tieren gewonnene menschliche polyklonale antikörper |
US6342587B1 (en) * | 1999-10-22 | 2002-01-29 | Ludwig Institute For Cancer Research | A33 antigen specific immunoglobulin products and uses thereof |
-
2000
- 2000-02-04 DE DE60023451T patent/DE60023451T2/de not_active Expired - Lifetime
- 2000-02-04 ES ES00907506T patent/ES2250105T3/es not_active Expired - Lifetime
- 2000-02-04 AT AT00907506T patent/ATE307830T1/de not_active IP Right Cessation
- 2000-02-04 JP JP2000597321A patent/JP5694623B2/ja not_active Expired - Lifetime
- 2000-02-04 WO PCT/EP2000/000933 patent/WO2000046251A2/en active IP Right Grant
- 2000-02-04 DK DK00907506T patent/DK1151010T3/da active
- 2000-02-04 AU AU29072/00A patent/AU2907200A/en not_active Abandoned
- 2000-02-04 EP EP00907506A patent/EP1151010B1/en not_active Expired - Lifetime
- 2000-02-04 CA CA2362098A patent/CA2362098C/en not_active Expired - Lifetime
-
2002
- 2002-06-26 US US10/183,093 patent/US20020178456A1/en not_active Abandoned
-
2008
- 2008-08-08 US US12/188,322 patent/US20080299112A1/en not_active Abandoned
-
2011
- 2011-12-27 JP JP2011285672A patent/JP6073550B2/ja not_active Expired - Lifetime
-
2015
- 2015-07-02 US US14/791,246 patent/US20150307595A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000046251A3 (en) | 2001-01-11 |
US20020178456A1 (en) | 2002-11-28 |
CA2362098A1 (en) | 2000-08-10 |
WO2000046251A2 (en) | 2000-08-10 |
JP6073550B2 (ja) | 2017-02-01 |
DE60023451T2 (de) | 2006-07-20 |
JP5694623B2 (ja) | 2015-04-01 |
DE60023451D1 (de) | 2005-12-01 |
US20150307595A1 (en) | 2015-10-29 |
EP1151010A2 (en) | 2001-11-07 |
CA2362098C (en) | 2011-10-11 |
JP2012072184A (ja) | 2012-04-12 |
AU2907200A (en) | 2000-08-25 |
EP1151010B1 (en) | 2005-10-26 |
ATE307830T1 (de) | 2005-11-15 |
ES2250105T3 (es) | 2006-04-16 |
US20080299112A1 (en) | 2008-12-04 |
JP2002540069A (ja) | 2002-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1151010T3 (da) | Humane polyklonale antistoffer fra antigene ikke-humane dyr | |
ATE390933T1 (de) | Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8 | |
Hansen | Vocal learning: its role in adapting sound structures to long-distance propagation, and a hypothesis on its evolution. | |
DE69933886D1 (de) | Transgene mäuse, die den menschliche immunoglobulinlambdalokus exprimieren | |
DK37290D0 (da) | Humant immunsystem i ikke-humane dyr | |
ATE211767T1 (de) | Dämpfung eines immundominanten epitops eines antigens zur verwendung für pflanzen, tierische und menschliche impstoffe und immuntherapien | |
IL114444A (en) | Kit for inducing immune response against a tumor or a disease caused by an infectious agent | |
DE60138832D1 (de) | Expression xenogener (menschlicher) immunglobuline in geklonten, transgenen rindern | |
ATE401787T1 (de) | Menschliches cd20 exprimierende transgene mäuse | |
ATE138104T1 (de) | Erzeugung von antikörpern aus transgenen tieren | |
NO943625D0 (no) | Monoklonale antistoffer mot interferonreseptoren med nöytraliserende aktivitet mot type-I-interferon | |
DE602004005055D1 (de) | Nahrungsmittelzusammensetzung | |
EE03285B1 (et) | Immuunsust stimuleerivad monoklonaalsed antikehad | |
NO912442D0 (no) | Kunstig agn for fisk, o.l. | |
NO910209L (no) | Fremgangsmaate for fremstilling av rekombinante humane anti-cd18-antistoffer. | |
WO2001019394A3 (en) | Immunotherapy with substantially human polyclonal antibody preparations purified from genetically engineered birds | |
ZA202213503B (en) | Genetically modified non-human animals with common light chain immunoglobulin locus | |
CA2010237A1 (en) | Humane leghold coiled spring trap | |
FR2671165B1 (fr) | Pied de lampadaire solaire. | |
DE60208447D1 (de) | Sprachverbindungssystem zwischen menschen und tieren | |
DK69690D0 (da) | Humane anti-rh(d) monoklonale antistoffer | |
Inger et al. | Larval transport in a Bornean ranid frog | |
Linzey | Postnatal growth and development of Peromyscus maniculatus nubiterrae | |
ATE407555T1 (de) | Efficienter kerntransfer mit primordialen keimzellen | |
EP1545195A4 (en) | ANIMAL MODEL OF PERIMENOPAUSE AND MENOPAUSE AND METHODS FOR INDUCING OVARIAN INSUFFICIENCY |